Singapore markets open in 5 hours 41 minutes

IGC Pharma, Inc. (IGC)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
0.5706+0.0168 (+3.03%)
As of 03:16PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Cash flows from operating activities
Net income
-14,145
-11,506
-15,016
-8,811
Depreciation & amortisation
626
657
651
478
Stock-based compensation
2,016
2,843
2,197
658
Change in working capital
1,871
794
2,536
-3,294
Accounts receivable
146
5
50
-42
Inventory
1,089
897
1,930
-1,233
Accounts payable
182
-451
504
-287
Other working capital
-6,550
-7,666
-8,233
-12,392
Other non-cash items
-
-
-430
-
Net cash provided by operating activities
-6,190
-7,047
-7,462
-10,800
Cash flows from investing activities
Investments in property, plant and equipment
-360
-619
-771
-1,592
Purchases of investments
-
-154
0
-149
Sales/maturities of investments
-
-
0
5,128
Net cash used for investing activities
-236
-235
-742
3,387
Cash flows from financing activities
Debt repayment
-4
-3
-3
-50
Common stock issued
2,860
103
4,145
14,158
Net cash used provided by (used for) financing activities
2,856
100
4,142
14,688
Net change in cash
-3,567
-7,264
-4,088
7,290
Cash at beginning of period
4,945
10,460
14,548
7,258
Cash at end of period
1,375
3,196
10,460
14,548
Free cash flow
Operating cash flow
-6,190
-7,047
-7,462
-10,800
Capital expenditure
-360
-619
-771
-1,592
Free cash flow
-6,550
-7,666
-8,233
-12,392